March 21, 2025 · Form 4 insider transaction
DSS, INC. sold 166,600 shares of IMPACT BIOMEDICAL INC at $3.30 per share, a transaction worth $549.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 7 days after the transaction.
This entity is a wholly-owned subsidiary of DSS, Inc.